Gut Hastasına Yaklaşım
Synopsis
Gout is an inflammatory condition more prevalent in men, primarily affecting the first metatarsophalangeal joint, which stems from hyperuricemia caused by an imbalance between uric acid production and excretion, leading to monosodium urate crystal deposits in tissues. Key triggers for flare-ups include trauma, surgery, alcohol consumption, thiazide diuretics, and starvation. The diagnostic gold standard involves detecting needle-shaped, negatively birefringent monosodium urate crystals in synovial fluid via polarized light microscopy. Additionally, direct radiography, the double contour sign (DCS) on ultrasound, and dual-energy computed tomography (DECT) serve as helpful imaging modalities. Regarding treatment, asymptomatic hyperuricemia requires no medical intervention, whereas NSAIDs (indomethacin) and colchicine represent the first-line therapies for acute attacks, with glucocorticoids reserved for cases where NSAIDs are contraindicated. Urate-lowering drugs are avoided during acute flares as they can exacerbate symptoms. For chronic cases presenting with frequent attacks or tophi, uric acid-lowering agents such as allopurinol, probenecid, and sulfinpyrazone are prescribed alongside lifestyle modifications and prophylactic colchicine.
References
Loeb JN. The effect of temperature on the solubility of monosodium urate. Arthritis Rheum 1972; 15: 189.
Joosten LA, Netea MG, Mylona E, et al. The interaction of fatty acids with Toll-like receptor 2 directs the production of interleukin-1β via the ASC / caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010; 62: 3237.
Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and risk of recurrent gout attacks: an online case-crossover study of gout. J Rheumatol 2006; 33: 1341.
Neogi T, Chen C, Niu J, et al. Amount and type of alcohol related to risk of recurrent gout attacks: an internet-based case study. Am J Med 2014; 127: 311.
Wortmann RL, Macdonald PA, Hunt B, Jackson RL. The effect of prophylaxis on gout exacerbations after initiation of urate-lowering therapy: analysis of data from the three phase III trials. Clin Ther 2010; 32: 2386.
Khanna D, Khanna PP, Fitzgerald JD, et al. 2012 American College of Rheumatology guidelines for treating gout. Part 2: Treatment and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1447.
McQueen FM, Doyle A, Dalbeth N. Imaging in crystal arthropathies. Rheum Dis Clin North Am 2014; 40: 231.
Thiele RG, Schlesinger N. Ultrasound diagnosis of gout. Rheumatology (Oxford) 2007; 46: 1116.
Chen LX, Schumacher HR. Current trends in crystal identification. Curr Opin Rheumatol 2006; 18: 171.